iA Global Asset Management Inc. Has $24.60 Million Stock Holdings in Danaher Corporation (NYSE:DHR)

Key Points

• iA Global Asset Management Inc. has increased its stock holdings in Danaher Corporation by 7.9%, now owning 119,995 shares valued at approximately $24.6 million.
• Chairman Steven M. Rales sold 1.25 million shares in a significant transaction, reducing his stake by 28.7% and retaining approximately $611 million in Danaher stock.
• Danaher reported quarterly earnings of $1.80 per share, surpassing analyst estimates, with revenue reaching $5.94 billion, a 3.4% increase from the previous year.

iA Global Asset Management Inc. raised its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 7.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 119,995 shares of the conglomerate's stock after buying an additional 8,819 shares during the quarter. iA Global Asset Management Inc.'s holdings in Danaher were worth $24,599,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the business. Heck Capital Advisors LLC bought a new position in shares of Danaher during the fourth quarter valued at $27,000. GHP Investment Advisors Inc. boosted its position in Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after buying an additional 99 shares in the last quarter. Sierra Ocean LLC grew its stake in Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after buying an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC bought a new stake in Danaher during the first quarter worth about $31,000. Finally, Dunhill Financial LLC increased its holdings in shares of Danaher by 68.4% during the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock worth $34,000 after buying an additional 67 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Trading Down 1.9%

NYSE DHR traded down $3.70 on Wednesday, reaching $195.34. The company had a trading volume of 5,123,027 shares, compared to its average volume of 4,690,992. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $279.90. The stock's 50 day moving average is $197.95 and its 200-day moving average is $201.85. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The stock has a market cap of $139.87 billion, a price-to-earnings ratio of 41.56, a PEG ratio of 2.77 and a beta of 0.73.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The company had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%. Danaher's revenue was up 3.4% on a year-over-year basis. During the same period in the prior year, the business posted $1.72 EPS. Equities analysts predict that Danaher Corporation will post 7.63 earnings per share for the current year.

Analyst Ratings Changes

DHR has been the topic of several recent analyst reports. Scotiabank raised Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 target price on the stock in a report on Friday, July 11th. Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a report on Friday, June 27th. JPMorgan Chase & Co. reduced their price target on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a research report on Tuesday, April 22nd. Leerink Partners raised their price objective on shares of Danaher from $225.00 to $230.00 and gave the company an "outperform" rating in a research report on Wednesday, April 23rd. Finally, The Goldman Sachs Group reduced their target price on shares of Danaher from $260.00 to $240.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 23rd. Three analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $247.61.

Insider Buying and Selling

In other news, Chairman Steven M. Rales sold 1,250,000 shares of Danaher stock in a transaction on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the transaction, the chairman directly owned 3,105,808 shares of the company's stock, valued at $611,036,665.92. This trade represents a 28.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 11.10% of the company's stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.